Prevalence of hypercalcemia in primary hypoadrenocorticism in dogs: Multicenter, retrospective study
Journal of Veterinary Internal Medicine · 2023
DOI: 10.1111/jvim.16786 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Journal of Veterinary Internal Medicine, 2023. Verfasst von Harriet Hall und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Veterinary Medicine, Queen's Veterinary School Hospital, University of Cambridge, Cambridge, United Kingdom. Hauptthemen laut MEDLINE: Hypercalcemia, Dog Diseases, Adrenal Insufficiency. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Hypoadrenocorticism is an important differential for hypercalcemia. The etiology of hypercalcemia in hypoadrenocorticism in dogs is unclear.
Objective
To review the prevalence of hypercalcemia and use statistical models to identify clinical, demographic, and biochemical variables associated with hypercalcemia in dogs with primary hypoadrenocorticism. Animals One hundred ten dogs with primary hypoadrenocorticism; 107 with recorded total calcium (TCa), 43 recorded ionized calcium (iCa).
Methods
Multicenter retrospective observational study at 4 UK referral hospitals. Univariable logistic regression analyses were performed to assess the association between independent variables of signalment, hypoadrenocorticism type (glucocorticoid only deficient hypoadrenocorticism [GHoC] vs glucocorticoid and mineralocorticoid deficient hypoadrenocorticism [GMHoC]), clinicopathological variables and hypercalcemia. Hypercalcemia was defined as elevated TCa, an elevated iCa, or both elevated TCa and iCa (Model 1) or as elevated iCa (Model 2).
Results
Overall prevalence of hypercalcemia was 34.5% (38/110). The odds of hypercalcemia (Model 1) were increased (P < .05) in dogs with GMHoC ([vs GHoC], OR [odds ratio] = 3.86, 95% confidence interval [CI] 1.105-13.463), higher serum creatinine (OR = 1.512, 95% CI 1.041-2.197), and higher serum albumin (OR = 4.187, 95% CI 1.744-10.048). The odds of ionized hypercalcemia (Model 2) were increased (P < .05) with reduced serum potassium concentration (OR = 0.401, 95% CI 0.184-0.876) and younger age (OR = 0.737, 95% CI 0.558-0.974). Conclusions and Clinical Importance This study identified several key clinical and biochemical variables associated with hypercalcemia in dogs with primary hypoadrenocorticism. These findings aid understanding of the pathophysiology and etiology of hypercalcemia in dogs with primary hypoadrenocorticism.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Veterinary Medicine, Queen's Veterinary School Hospital, University of Cambridge, Cambridge, United Kingdom.
- Dick White Referrals, Six Mile Bottom, Cambridgeshire, United Kingdom.
- Langford Vets, Bristol Veterinary School, Langford House, Langford BS40 5DU, United Kingdom.
- Davies Veterinary Specialists, Manor Farm Business Park, Higham Gobion, Hitchin, United Kingdom.
ORCID-Profile: Harriet Hall, Jessica Florey
Zitieren
APA
Hall, H., Williams, T., Florey, J., Moreno, M. P., Black, V., Thompson, D., & Skelly, B. (2023). Prevalence of hypercalcemia in primary hypoadrenocorticism in dogs: Multicenter, retrospective study. Journal of Veterinary Internal Medicine. https://doi.org/10.1111/jvim.16786
Vancouver
Hall H, Williams T, Florey J, Moreno MP, Black V, Thompson D, et al. Prevalence of hypercalcemia in primary hypoadrenocorticism in dogs: Multicenter, retrospective study. Journal of Veterinary Internal Medicine. 2023. doi:10.1111/jvim.16786
BibTeX
@article{Hall2023,
author = {Hall, Harriet and Williams, Timothy and Florey, Jessica and Moreno, Mireia Pascual and Black, Victoria and Thompson, Daniel and Skelly, Barbara},
title = {Prevalence of hypercalcemia in primary hypoadrenocorticism in dogs: Multicenter, retrospective study},
journal = {Journal of Veterinary Internal Medicine},
year = {2023},
doi = {10.1111/jvim.16786}
}
EUVIMED